aTyr Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.02 Billion, with shareholders equity totaling $-24.12 Millions.
The company employs approximately 44 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, aTyr Pharma Inc. reported $110.08 Millions in revenue, generating net income of $9.80 Millions.
Key financial metrics include a P/E ratio of 104.14, a price-to-book (P/B) ratio of -42.31, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker LIFE.